High-dose epinephrine in pediatric out-of-hospital cardiopulmonary arrest

To compare the efficacy of high-dose epinephrine (HDE) and standard-dose epinephrine (SDE) for out-of-hospital treatment of pediatric cardiopulmonary arrest (CPA). Forty-eight-month retrospective cohort study. Prehospital emergency medical services (EMS) system of a large metropolitan region. All ch...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatrics (Evanston) 1995-06, Vol.95 (6), p.901-913
Hauptverfasser: DIECKMANN, R. A, VARDIS, R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 913
container_issue 6
container_start_page 901
container_title Pediatrics (Evanston)
container_volume 95
creator DIECKMANN, R. A
VARDIS, R
description To compare the efficacy of high-dose epinephrine (HDE) and standard-dose epinephrine (SDE) for out-of-hospital treatment of pediatric cardiopulmonary arrest (CPA). Forty-eight-month retrospective cohort study. Prehospital emergency medical services (EMS) system of a large metropolitan region. All children younger than 18 years of age, who suffered nontraumatic CPA, did not meet local EMS criteria for death in the field, and were treated by paramedics according to EMS pediatric CPA protocols. Paramedics administered HDE (> 0.1 mg/kg), SDE (< 0.1 mg/kg), or no epinephrine (NE), based on base hospital physician order and availability of access for drug delivery. Protocols permitted either HDE or SDE. The drug was given through an endotracheal tube, intraosseous line, or intravenous line. Return of spontaneous circulation (ROSC) and return of an organized electrical rhythm (ROER) in the ambulance and emergency department, hospital admission, hospital discharge, and short- and long-term neurologic outcome by pediatric cerebral performance category (PCPC) score. During the study period, 65 children met inclusion criteria and underwent attempted out-of-hospital resuscitation. Forty patients (62%) received HDE (mean dose +/- SD, 0.19 +/- 0.06 mg/kg); 13 patients (20%) received SDE (mean dose +/- SD, 0.02 +/- 0.02 mg/kg); and 12 patients (18%) received NE. The HDE and SDE groups were statistically different only in epinephrine dose but not in age, gender, proportion of asystolic presenting rhythms, success of endotracheal tube intubation or intraosseous line insertion, rate of ROSC, rate of ROER, survival, or proportion of sudden infant death syndrome final diagnoses. Fifty-four children (83%) presented in asystole, 5 (8%) had pulseless electrical activity (PEA), and 6 (9%) had ventricular fibrillation (VF). None presented with either supraventricular tachycardia or ventricular tachycardia. Thirty-nine patients receiving HDE had asystole or VF as presenting rhythms, 4 (10%) had ROER, and 1 had ROSC. The single child receiving HDE presenting with PEA did not have ROSC. Ten patients receiving SDE had asystole or VF, 2 (20%) had ROER, and none had ROSC. There were 3 children receiving SDE who had PEA, and 1 had ROSC. Eleven patients receiving NE had asystole or VF, and none had ROER. One child receiving NE had PEA and ROSC. Altogether, 1 patient receiving HDE, 1 receiving SDE, and 1 receiving NE had ROSC in the field, which continued in the emergency department; all 3
doi_str_mv 10.1542/peds.95.6.901
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_77289867</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A17166564</galeid><sourcerecordid>A17166564</sourcerecordid><originalsourceid>FETCH-LOGICAL-c489t-ac21ed1e2d362c26d2df77a0751d5cd03fb854084ca3d93000b3693bcdcf1f793</originalsourceid><addsrcrecordid>eNpt0s1rHCEUAHApLek27bHHwlBK6SGz9WPU8RiWNgks5NKexdXnrMEdpzoD6X9flyyBlEVQ8P3Qx3sPoY8Erwnv6PcJXFkrvhZrhckrtCJY9W1HJX-NVhgz0nYY87foXSkPGOOOS3qBLqQUhBK1Qne3Ydi3LhVoYAojTPtc9yaMTX03mDkH26RlbpNv96lMYTaxsSa7kKYlHtJo8t_G5Axlfo_eeBMLfDidl-j3zx-_Nrft9v7mbnO9bW3Xq7k1lhJwBKhjgloqHHVeSoMlJ45bh5nf9bzDfWcNc4rVlHdMKLazznripWKX6OvTu1NOf5b6sT6EYiFGM0JaipaS9qoXssLP_8GHtOSx5qYp7dmRHdHVExpMBB1Gn-Zs7AAjZBPTCD7U62siiRBcdJW3Z3hdDg7BnvPfXvhKZnicB7OUovub7Qt6dY7aFCMMoGsNN_fnMrE5lZLB6ymHQ22HJlgfB0MfB0MrroWug1H9p1M1lt0B3LM-TUKNfznFTbEm-mxGG8ozY7y2Cwv2DwxfvpA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>228372897</pqid></control><display><type>article</type><title>High-dose epinephrine in pediatric out-of-hospital cardiopulmonary arrest</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>DIECKMANN, R. A ; VARDIS, R</creator><creatorcontrib>DIECKMANN, R. A ; VARDIS, R</creatorcontrib><description>To compare the efficacy of high-dose epinephrine (HDE) and standard-dose epinephrine (SDE) for out-of-hospital treatment of pediatric cardiopulmonary arrest (CPA). Forty-eight-month retrospective cohort study. Prehospital emergency medical services (EMS) system of a large metropolitan region. All children younger than 18 years of age, who suffered nontraumatic CPA, did not meet local EMS criteria for death in the field, and were treated by paramedics according to EMS pediatric CPA protocols. Paramedics administered HDE (&gt; 0.1 mg/kg), SDE (&lt; 0.1 mg/kg), or no epinephrine (NE), based on base hospital physician order and availability of access for drug delivery. Protocols permitted either HDE or SDE. The drug was given through an endotracheal tube, intraosseous line, or intravenous line. Return of spontaneous circulation (ROSC) and return of an organized electrical rhythm (ROER) in the ambulance and emergency department, hospital admission, hospital discharge, and short- and long-term neurologic outcome by pediatric cerebral performance category (PCPC) score. During the study period, 65 children met inclusion criteria and underwent attempted out-of-hospital resuscitation. Forty patients (62%) received HDE (mean dose +/- SD, 0.19 +/- 0.06 mg/kg); 13 patients (20%) received SDE (mean dose +/- SD, 0.02 +/- 0.02 mg/kg); and 12 patients (18%) received NE. The HDE and SDE groups were statistically different only in epinephrine dose but not in age, gender, proportion of asystolic presenting rhythms, success of endotracheal tube intubation or intraosseous line insertion, rate of ROSC, rate of ROER, survival, or proportion of sudden infant death syndrome final diagnoses. Fifty-four children (83%) presented in asystole, 5 (8%) had pulseless electrical activity (PEA), and 6 (9%) had ventricular fibrillation (VF). None presented with either supraventricular tachycardia or ventricular tachycardia. Thirty-nine patients receiving HDE had asystole or VF as presenting rhythms, 4 (10%) had ROER, and 1 had ROSC. The single child receiving HDE presenting with PEA did not have ROSC. Ten patients receiving SDE had asystole or VF, 2 (20%) had ROER, and none had ROSC. There were 3 children receiving SDE who had PEA, and 1 had ROSC. Eleven patients receiving NE had asystole or VF, and none had ROER. One child receiving NE had PEA and ROSC. Altogether, 1 patient receiving HDE, 1 receiving SDE, and 1 receiving NE had ROSC in the field, which continued in the emergency department; all 3 were admitted to the hospital. Two children (3%), 1 receiving HDE and 1 receiving SDE, survived to hospital discharge. The survivor receiving HDE had spastic quadriplegia and profound neurologic handicaps at discharge, with a PCPC score of 4 (severe disability with daily living milestones below the 10th percentile and excessive dependence on others for provision of activities of daily living); at a 1-year follow-up, she had a PCPC score of 4. The survivor receiving SDE was neurologically healthy at discharge; at discharge and at follow-up at age 1 year, she had a PCPC score of 1 (age-appropriate level of functioning and developmentally appropriate). HDE does not seem to improve the rates of ROER and ROSC, hospital admission, survival, or neurologic outcome when compared with SDE for treatment of out-of-hospital pediatric CPA. A large, blinded prospective clinical trial testing different epinephrine doses is necessary to determine drug efficacy and safety. Future pediatric CPA studies must standardize reporting of core data elements, using the adult Utstein criteria modified for pediatrics, to allow valid treatment comparisons. Overall, survival in out-of-hospital pediatric CPA is dismal.(ABSTRACT TRUNCATED)</description><identifier>ISSN: 0031-4005</identifier><identifier>EISSN: 1098-4275</identifier><identifier>DOI: 10.1542/peds.95.6.901</identifier><identifier>PMID: 7761219</identifier><identifier>CODEN: PEDIAU</identifier><language>eng</language><publisher>Elk Grove Village, IL: American Academy of Pediatrics</publisher><subject>Adolescent ; Algorithms ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Cardiac arrest ; Cardiac arrest in children ; Cardiovascular disease ; Cardiovascular system ; Child ; Child, Preschool ; Clinical Protocols ; Cohort Studies ; Dosage and administration ; Drug therapy ; Electrocardiography ; Emergency and intensive cardiocirculatory care. Cardiogenic shock. Coronary intensive care ; Emergency Medical Services ; Epinephrine ; Epinephrine - administration &amp; dosage ; Heart Arrest - diagnosis ; Heart Arrest - drug therapy ; Humans ; Infant ; Intensive care medicine ; Medical research ; Medical sciences ; Miscellaneous ; Pediatric cardiology ; Pediatrics ; Pharmacology. Drug treatments ; Resuscitation - methods ; Retrospective Studies ; Treatment Outcome</subject><ispartof>Pediatrics (Evanston), 1995-06, Vol.95 (6), p.901-913</ispartof><rights>1995 INIST-CNRS</rights><rights>COPYRIGHT 1995 American Academy of Pediatrics</rights><rights>COPYRIGHT 1995 American Academy of Pediatrics</rights><rights>Copyright American Academy of Pediatrics Jun 1995</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c489t-ac21ed1e2d362c26d2df77a0751d5cd03fb854084ca3d93000b3693bcdcf1f793</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>310,311,315,781,785,790,791,23935,23936,25145,27929,27930</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3536206$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7761219$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DIECKMANN, R. A</creatorcontrib><creatorcontrib>VARDIS, R</creatorcontrib><title>High-dose epinephrine in pediatric out-of-hospital cardiopulmonary arrest</title><title>Pediatrics (Evanston)</title><addtitle>Pediatrics</addtitle><description>To compare the efficacy of high-dose epinephrine (HDE) and standard-dose epinephrine (SDE) for out-of-hospital treatment of pediatric cardiopulmonary arrest (CPA). Forty-eight-month retrospective cohort study. Prehospital emergency medical services (EMS) system of a large metropolitan region. All children younger than 18 years of age, who suffered nontraumatic CPA, did not meet local EMS criteria for death in the field, and were treated by paramedics according to EMS pediatric CPA protocols. Paramedics administered HDE (&gt; 0.1 mg/kg), SDE (&lt; 0.1 mg/kg), or no epinephrine (NE), based on base hospital physician order and availability of access for drug delivery. Protocols permitted either HDE or SDE. The drug was given through an endotracheal tube, intraosseous line, or intravenous line. Return of spontaneous circulation (ROSC) and return of an organized electrical rhythm (ROER) in the ambulance and emergency department, hospital admission, hospital discharge, and short- and long-term neurologic outcome by pediatric cerebral performance category (PCPC) score. During the study period, 65 children met inclusion criteria and underwent attempted out-of-hospital resuscitation. Forty patients (62%) received HDE (mean dose +/- SD, 0.19 +/- 0.06 mg/kg); 13 patients (20%) received SDE (mean dose +/- SD, 0.02 +/- 0.02 mg/kg); and 12 patients (18%) received NE. The HDE and SDE groups were statistically different only in epinephrine dose but not in age, gender, proportion of asystolic presenting rhythms, success of endotracheal tube intubation or intraosseous line insertion, rate of ROSC, rate of ROER, survival, or proportion of sudden infant death syndrome final diagnoses. Fifty-four children (83%) presented in asystole, 5 (8%) had pulseless electrical activity (PEA), and 6 (9%) had ventricular fibrillation (VF). None presented with either supraventricular tachycardia or ventricular tachycardia. Thirty-nine patients receiving HDE had asystole or VF as presenting rhythms, 4 (10%) had ROER, and 1 had ROSC. The single child receiving HDE presenting with PEA did not have ROSC. Ten patients receiving SDE had asystole or VF, 2 (20%) had ROER, and none had ROSC. There were 3 children receiving SDE who had PEA, and 1 had ROSC. Eleven patients receiving NE had asystole or VF, and none had ROER. One child receiving NE had PEA and ROSC. Altogether, 1 patient receiving HDE, 1 receiving SDE, and 1 receiving NE had ROSC in the field, which continued in the emergency department; all 3 were admitted to the hospital. Two children (3%), 1 receiving HDE and 1 receiving SDE, survived to hospital discharge. The survivor receiving HDE had spastic quadriplegia and profound neurologic handicaps at discharge, with a PCPC score of 4 (severe disability with daily living milestones below the 10th percentile and excessive dependence on others for provision of activities of daily living); at a 1-year follow-up, she had a PCPC score of 4. The survivor receiving SDE was neurologically healthy at discharge; at discharge and at follow-up at age 1 year, she had a PCPC score of 1 (age-appropriate level of functioning and developmentally appropriate). HDE does not seem to improve the rates of ROER and ROSC, hospital admission, survival, or neurologic outcome when compared with SDE for treatment of out-of-hospital pediatric CPA. A large, blinded prospective clinical trial testing different epinephrine doses is necessary to determine drug efficacy and safety. Future pediatric CPA studies must standardize reporting of core data elements, using the adult Utstein criteria modified for pediatrics, to allow valid treatment comparisons. Overall, survival in out-of-hospital pediatric CPA is dismal.(ABSTRACT TRUNCATED)</description><subject>Adolescent</subject><subject>Algorithms</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Cardiac arrest</subject><subject>Cardiac arrest in children</subject><subject>Cardiovascular disease</subject><subject>Cardiovascular system</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Clinical Protocols</subject><subject>Cohort Studies</subject><subject>Dosage and administration</subject><subject>Drug therapy</subject><subject>Electrocardiography</subject><subject>Emergency and intensive cardiocirculatory care. Cardiogenic shock. Coronary intensive care</subject><subject>Emergency Medical Services</subject><subject>Epinephrine</subject><subject>Epinephrine - administration &amp; dosage</subject><subject>Heart Arrest - diagnosis</subject><subject>Heart Arrest - drug therapy</subject><subject>Humans</subject><subject>Infant</subject><subject>Intensive care medicine</subject><subject>Medical research</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Pediatric cardiology</subject><subject>Pediatrics</subject><subject>Pharmacology. Drug treatments</subject><subject>Resuscitation - methods</subject><subject>Retrospective Studies</subject><subject>Treatment Outcome</subject><issn>0031-4005</issn><issn>1098-4275</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0s1rHCEUAHApLek27bHHwlBK6SGz9WPU8RiWNgks5NKexdXnrMEdpzoD6X9flyyBlEVQ8P3Qx3sPoY8Erwnv6PcJXFkrvhZrhckrtCJY9W1HJX-NVhgz0nYY87foXSkPGOOOS3qBLqQUhBK1Qne3Ydi3LhVoYAojTPtc9yaMTX03mDkH26RlbpNv96lMYTaxsSa7kKYlHtJo8t_G5Axlfo_eeBMLfDidl-j3zx-_Nrft9v7mbnO9bW3Xq7k1lhJwBKhjgloqHHVeSoMlJ45bh5nf9bzDfWcNc4rVlHdMKLazznripWKX6OvTu1NOf5b6sT6EYiFGM0JaipaS9qoXssLP_8GHtOSx5qYp7dmRHdHVExpMBB1Gn-Zs7AAjZBPTCD7U62siiRBcdJW3Z3hdDg7BnvPfXvhKZnicB7OUovub7Qt6dY7aFCMMoGsNN_fnMrE5lZLB6ymHQ22HJlgfB0MfB0MrroWug1H9p1M1lt0B3LM-TUKNfznFTbEm-mxGG8ozY7y2Cwv2DwxfvpA</recordid><startdate>19950601</startdate><enddate>19950601</enddate><creator>DIECKMANN, R. A</creator><creator>VARDIS, R</creator><general>American Academy of Pediatrics</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8GL</scope><scope>7TS</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>U9A</scope><scope>7X8</scope></search><sort><creationdate>19950601</creationdate><title>High-dose epinephrine in pediatric out-of-hospital cardiopulmonary arrest</title><author>DIECKMANN, R. A ; VARDIS, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c489t-ac21ed1e2d362c26d2df77a0751d5cd03fb854084ca3d93000b3693bcdcf1f793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Adolescent</topic><topic>Algorithms</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Cardiac arrest</topic><topic>Cardiac arrest in children</topic><topic>Cardiovascular disease</topic><topic>Cardiovascular system</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Clinical Protocols</topic><topic>Cohort Studies</topic><topic>Dosage and administration</topic><topic>Drug therapy</topic><topic>Electrocardiography</topic><topic>Emergency and intensive cardiocirculatory care. Cardiogenic shock. Coronary intensive care</topic><topic>Emergency Medical Services</topic><topic>Epinephrine</topic><topic>Epinephrine - administration &amp; dosage</topic><topic>Heart Arrest - diagnosis</topic><topic>Heart Arrest - drug therapy</topic><topic>Humans</topic><topic>Infant</topic><topic>Intensive care medicine</topic><topic>Medical research</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Pediatric cardiology</topic><topic>Pediatrics</topic><topic>Pharmacology. Drug treatments</topic><topic>Resuscitation - methods</topic><topic>Retrospective Studies</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DIECKMANN, R. A</creatorcontrib><creatorcontrib>VARDIS, R</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: High School</collection><collection>Physical Education Index</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatrics (Evanston)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DIECKMANN, R. A</au><au>VARDIS, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High-dose epinephrine in pediatric out-of-hospital cardiopulmonary arrest</atitle><jtitle>Pediatrics (Evanston)</jtitle><addtitle>Pediatrics</addtitle><date>1995-06-01</date><risdate>1995</risdate><volume>95</volume><issue>6</issue><spage>901</spage><epage>913</epage><pages>901-913</pages><issn>0031-4005</issn><eissn>1098-4275</eissn><coden>PEDIAU</coden><abstract>To compare the efficacy of high-dose epinephrine (HDE) and standard-dose epinephrine (SDE) for out-of-hospital treatment of pediatric cardiopulmonary arrest (CPA). Forty-eight-month retrospective cohort study. Prehospital emergency medical services (EMS) system of a large metropolitan region. All children younger than 18 years of age, who suffered nontraumatic CPA, did not meet local EMS criteria for death in the field, and were treated by paramedics according to EMS pediatric CPA protocols. Paramedics administered HDE (&gt; 0.1 mg/kg), SDE (&lt; 0.1 mg/kg), or no epinephrine (NE), based on base hospital physician order and availability of access for drug delivery. Protocols permitted either HDE or SDE. The drug was given through an endotracheal tube, intraosseous line, or intravenous line. Return of spontaneous circulation (ROSC) and return of an organized electrical rhythm (ROER) in the ambulance and emergency department, hospital admission, hospital discharge, and short- and long-term neurologic outcome by pediatric cerebral performance category (PCPC) score. During the study period, 65 children met inclusion criteria and underwent attempted out-of-hospital resuscitation. Forty patients (62%) received HDE (mean dose +/- SD, 0.19 +/- 0.06 mg/kg); 13 patients (20%) received SDE (mean dose +/- SD, 0.02 +/- 0.02 mg/kg); and 12 patients (18%) received NE. The HDE and SDE groups were statistically different only in epinephrine dose but not in age, gender, proportion of asystolic presenting rhythms, success of endotracheal tube intubation or intraosseous line insertion, rate of ROSC, rate of ROER, survival, or proportion of sudden infant death syndrome final diagnoses. Fifty-four children (83%) presented in asystole, 5 (8%) had pulseless electrical activity (PEA), and 6 (9%) had ventricular fibrillation (VF). None presented with either supraventricular tachycardia or ventricular tachycardia. Thirty-nine patients receiving HDE had asystole or VF as presenting rhythms, 4 (10%) had ROER, and 1 had ROSC. The single child receiving HDE presenting with PEA did not have ROSC. Ten patients receiving SDE had asystole or VF, 2 (20%) had ROER, and none had ROSC. There were 3 children receiving SDE who had PEA, and 1 had ROSC. Eleven patients receiving NE had asystole or VF, and none had ROER. One child receiving NE had PEA and ROSC. Altogether, 1 patient receiving HDE, 1 receiving SDE, and 1 receiving NE had ROSC in the field, which continued in the emergency department; all 3 were admitted to the hospital. Two children (3%), 1 receiving HDE and 1 receiving SDE, survived to hospital discharge. The survivor receiving HDE had spastic quadriplegia and profound neurologic handicaps at discharge, with a PCPC score of 4 (severe disability with daily living milestones below the 10th percentile and excessive dependence on others for provision of activities of daily living); at a 1-year follow-up, she had a PCPC score of 4. The survivor receiving SDE was neurologically healthy at discharge; at discharge and at follow-up at age 1 year, she had a PCPC score of 1 (age-appropriate level of functioning and developmentally appropriate). HDE does not seem to improve the rates of ROER and ROSC, hospital admission, survival, or neurologic outcome when compared with SDE for treatment of out-of-hospital pediatric CPA. A large, blinded prospective clinical trial testing different epinephrine doses is necessary to determine drug efficacy and safety. Future pediatric CPA studies must standardize reporting of core data elements, using the adult Utstein criteria modified for pediatrics, to allow valid treatment comparisons. Overall, survival in out-of-hospital pediatric CPA is dismal.(ABSTRACT TRUNCATED)</abstract><cop>Elk Grove Village, IL</cop><pub>American Academy of Pediatrics</pub><pmid>7761219</pmid><doi>10.1542/peds.95.6.901</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0031-4005
ispartof Pediatrics (Evanston), 1995-06, Vol.95 (6), p.901-913
issn 0031-4005
1098-4275
language eng
recordid cdi_proquest_miscellaneous_77289867
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Adolescent
Algorithms
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
Cardiac arrest
Cardiac arrest in children
Cardiovascular disease
Cardiovascular system
Child
Child, Preschool
Clinical Protocols
Cohort Studies
Dosage and administration
Drug therapy
Electrocardiography
Emergency and intensive cardiocirculatory care. Cardiogenic shock. Coronary intensive care
Emergency Medical Services
Epinephrine
Epinephrine - administration & dosage
Heart Arrest - diagnosis
Heart Arrest - drug therapy
Humans
Infant
Intensive care medicine
Medical research
Medical sciences
Miscellaneous
Pediatric cardiology
Pediatrics
Pharmacology. Drug treatments
Resuscitation - methods
Retrospective Studies
Treatment Outcome
title High-dose epinephrine in pediatric out-of-hospital cardiopulmonary arrest
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T14%3A03%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High-dose%20epinephrine%20in%20pediatric%20out-of-hospital%20cardiopulmonary%20arrest&rft.jtitle=Pediatrics%20(Evanston)&rft.au=DIECKMANN,%20R.%20A&rft.date=1995-06-01&rft.volume=95&rft.issue=6&rft.spage=901&rft.epage=913&rft.pages=901-913&rft.issn=0031-4005&rft.eissn=1098-4275&rft.coden=PEDIAU&rft_id=info:doi/10.1542/peds.95.6.901&rft_dat=%3Cgale_proqu%3EA17166564%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=228372897&rft_id=info:pmid/7761219&rft_galeid=A17166564&rfr_iscdi=true